Recent advances in the pharmacological management of painful diabetic neuropathy

British Journal of Diabetes and Vascular Disease

Volumn 9, Issue 6, 2009, Pages 283-287

  Tesfaye, Solomon ^a   Selvarajah, Dinesh ^a  

^a NONE

Author keywords

Diabetic peripheral neuropathy; DPN; Pain therapy

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CAPSAICIN; DULOXETINE; GABAPENTIN; IMIPRAMINE; MORPHINE; MORPHINE SULFATE; OPIATE AGONIST; OXYCODONE; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; THIOCTIC ACID; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL FEATURE; COMORBIDITY; DIABETIC NEUROPATHY; DIZZINESS; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG USE; HEART DEATH; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEMBRANE STABILIZATION; NAUSEA; NEURITIS; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SWEATING; XEROSTOMIA;

EID: 74549137829     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651409351658     Document Type: Review

References (34)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Int Med 1995;122:561-568
2. Tesfaye S, Chaturvedi N, Eaton SEM et al. Vascular risk factors and diabetic neuropathy. New Engl J Med 2005; 352:341-350
3. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464-469
4. Wiggin TD, Sullivan KA, Pop-Busui R et al. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 2009;58:1634-1640
5. Tesfaye S. Diabetic neuropathy: achieving best practice. Br J Vasc Dis 2003;3:112-117
6. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 2000;47:123-128
7. Quattrini C, Tesfaye S. Understanding the impact of painful diabetic neuropathy. Diabetes Metab Res Rev 2003;19:S2-S8.
8. Partanen J, Niskanen L, Lehtinen J et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89-94
9. Daousi C, MacFarlane IA, Woodward A et al. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med 2004;21:976-982
10. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29:1518-1522
11. Gemignani F. Acute painful diabetic neuropathy induced by strict glycemic control ("insulin neuritis"): the old enigma is still unsolved. Biomed Pharmacother 2009;63:249-250
12. Tesfaye S, Malik R, Harris N et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 1996;39:329-335
13. Archer AG, Watkins PJ, Thomas PJ et al. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neorosurg Psychiatr 1983;46:491-496
14. Ellenberg M. Diabetic neuropathic cachexia. Diabetes 1974;23:418-423
15. Dabby R, Sadeh M, Lampl Y et al. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients. Biomed Pharmacother 2008. [Epub ahead of print]
16. Finnerup NB, Otto M, McQuay HJ et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118:289-305.
17. Max MB, Lynch SA, Muir J et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-1256
18. Ray WA, Meredith S, Thapa PB et al. Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 2004;75:234-241 (Pubitemid 38314873)
19. Goldstein DJ, Lu Y, Detke MJ et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005;116:109-118
20. Raskin J, Pritchett YL, Wang F et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005a;6: 346-356
21. Wernicke JF, Pritchett YL, D'Souza DN et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006 Oct 24;67:1411-1420
22. Kajdasz DK, Iyengar S, Desaiah et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo- controlled, parallel-group studies. Clin Ther 2007;29 Suppl:2536-2546
23. Backonja M, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomised controlled trial. JAMA 1998; 280: 1831-1836
24. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety and tolerability of pregabalin treatment of painful diabetic peripheral neuropathy: findings from 7 randomized, controlled trials across a range of doses. Diabetes Care 2008;31:1448-1454
25. Harati Y, Gooch C, Swenson M et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;52:1842-1846
26. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology 2003;60:927-934
27. Gilron I, Bailey JM, Tu D et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005;352:1324-1334
28. Hanna M, O'Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008;12:804-13.
29. Capsaicin Study Group. The effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Diabetes Care 1992;15:159-165
30. Ziegler D, Nowak H, Kempler P et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a metaanalysis. Diabetic Med 2004;21:114-121 (Pubitemid 38221809)
31. Ziegler D, Ametov A, Barinov A et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006;29:2365-2370
32. Jensen TS, Backonja MM, Hernandez Jimenez S et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res 2006;3:108-119.
33. National Institute for Health and Clinical Excellence (NICE) CG 87 Type 2 diabetes: the management of type 2 diabetes. London: NICE, 2009.
34. Tesfaye S. Advances in the management of painful diabetic neuropathy. Curr Opin Support Palliat Care 2009 Jun;3:136-143